DR. JOSEPH DAVID ROSEN MD NPI 1225002413

NPI Details

DR. Joseph David Rosen, MD is a medical oncology internal medicine in Sun City, AZ with 37 years of experience. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. DR. Joseph David Rosen, MD NPI is 1225002413. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF CHICAGO, PRITZKER SCHOOL OF MEDICINE
Graduation Year:1989

The provider's business location address is:

13041 N DEL WEBB BLVD, STE 200
SUN CITY, AZ
ZIP 85351
Phone: (480) 256-6444
Fax: (623) 285-2801

The NPI 1225002413 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, fosaprepitant, 1 mg (HCPCS:J1453)
• Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg (HCPCS:Q5119)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Injection, pegfilgrastim-apgf, biosimilar, (nyvepria), 0.5 mg (HCPCS:Q5122)
• Injection, potassium chloride, per 2 meq (HCPCS:J3480)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
• Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session (HCPCS:G6015)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Ct guidance for insertion of radiation therapy fields (HCPCS:77014)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy (HCPCS:G6002)
• Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
• Magnesium level (HCPCS:83735)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev (HCPCS:G6013)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Ferritin (blood protein) level (HCPCS:82728)
• Ct scan of chest with contrast (HCPCS:71260)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
• Continuing radiation therapy consultation per week (HCPCS:77336)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 125 (HCPCS:86304)
• Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev (HCPCS:G6012)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Irrigation of implanted venous access drug delivery device (HCPCS:96523)
• Uric acid level, blood (HCPCS:84550)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Iron binding capacity (HCPCS:83550)
• Iron level (HCPCS:83540)
• Injection, alteplase recombinant, 1 mg (HCPCS:J2997)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Ct scan of chest without contrast (HCPCS:71250)
• Obtaining data needed to develop the optimal radiation treatment, 1 treatment area (HCPCS:77280)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Special radiation treatment (HCPCS:77470)
• Ct scan of abdomen and pelvis without contrast (HCPCS:74176)

The enumeration date for this NPI number is 2/14/2006 and was last updated on 7/15/2025.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.